The Sims 3 | Perfect Genetics Challenge Part 11: Walking Toddlers In this part, we teach the twins how to walk and find out we're pregnant! Backstory: "Once upon a time, the Mighty Player sent a Sim to live in the world whe... By: simplyapril … Continue reading →

TS3-Midnight sun-Perfect genetics Challenge part 1 Kurtis Gilbert belongs to the people of seamen. He is ten years old and the only one left of his kind that have become extinct by the people. Kurtis has just arrived to an island that nobody... By: PinkButterflyStudios … Continue reading →

The Sims 3 | Perfect Genetics Challenge Part 12: Makeovers! In this part, the twins age up with some technical difficulties 🙁 Sorry if you hear my family making a whole bunch of noises in the background, i'll record ... By: simplyapril … Continue reading →

New genetics from Canada of milking shorthorns through embryo transfer are in a Manawatu calf shed. Hiwinui dairy farmer David Wood said seven embryos were carried in beef cows and three were yet to be born. Four had been born, three bull calves and a heifer. "The whole idea was to bring in new genetics for my herd," Wood said. There are few herds of milking shorthorns in New Zealand; most dairy cows are jersey, holstein friesian or a cross. The sire of the embryos was Kulp- Gen Jurist ACE and the embryos were flushed from the Canadian cow Oceanbrae n Missy. Wood is hopeful the unborn embryos will be heifers and go into his herd. The bulls and heifer are not named yet, but Wood thinks the week-old heifer will be Northbrook Missy, named after her mother. The bulls will stay on the farm, with hairs sent to Canada to check their breeding worth. The Hawke's Bay-based company, EmbryoCo, transplanted 10 embryos and seven took - a success, Wood said. Read the original here: Genetics success from transplanted embryos … Continue reading →

On July 9, we issued an updated research report on leading molecular diagnostic company Myriad Genetics Inc. ( MYGN ). While we are impressed with the company's strong fundamentals, as once again reflected in the last reported quarter's financial performance, we believe emerging competitors and pricing pressure amid a challenging macroeconomic scenario might plague the stock in the future. Myriad Genetics' third-quarter fiscal 2014 earnings per share came in at 60 cents, registering a stupendous 30.4% beat over the Zacks Consensus Estimate. Earnings also exceeded the year-over-year adjusted EPS number by the same margin. Likewise, revenues increased 17% to $182.9 million, topping the Zacks Consensus Estimate of $174 million. According to the company, it is perfectly in sync with its strategic initiatives of expanding the core hereditary cancer market, growing its international business and launching new life-saving products. Banking on core market growth, specifically the Oncology and Women's Health business that led to another solid quarter, and several recent positive takeaways including the recent acquisition of Crescendo Bioscience; the three-year contract with United Healthcare to provide coverage for Myriad Genetics' myRisk Hereditary Cancer test; and the collaboration with Tesaro for the use of Myriad Genetics' proprietary HRD test to identify … Continue reading →

Contact Information Available for logged-in reporters only Newswise RUCDR Infinite Biologics, a unit of Rutgers Human Genetics Institute of New Jersey, has taken a major step toward expanding its focus from conducting and supporting genomic research, where its become a recognized global leader, to the rapidly growing field of clinical genomics. RUCDR, which is the worlds largest university-based biorepository, recently earned its initial certification from the federal Clinical Laboratory Improvement Amendments program. CLIA, as its commonly known in health care, is run by the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services. CMS mandates that all tests for the diagnosis, treatment and prognosis of disease in human subjects be carried out in a CLIA-certified laboratory. Certification is granted only after an operation undergoes a rigorous review, including on-site inspection. The State of New Jersey also recently awarded the new lab at Rutgers a Clinical Laboratory Improvement Services license. Building on 15 years of innovative and globally influential genomics research operations and services, RUCDR aims to provide clinical-grade diagnostics for a wide variety of diseases. In the first instance, RUCDR plans to support the precision medicine program and advanced treatment protocols being developed … Continue reading →